Hae-Sun Kim

Title: Innovations in Dementia Treatment: The Contributions of Hae-Sun Kim

Introduction: Hae-Sun Kim, an esteemed inventor based in Seongnam-si, South Korea, has made significant strides in the field of pharmaceutical innovations. With a focus on improving treatments for dementia, Kim's work exemplifies the intersection of science and invention.

Latest Patents: Hae-Sun Kim holds a patent for a percutaneous absorption preparation designed for treating dementia through donepezil. This innovative formulation incorporates donepezil or its pharmaceutically acceptable salt as the active component, propylene glycol monocaprylate as a solubilizer, and styrene-isoprene-styrene block copolymer (SIS) as an adhesive. Notably, this preparation is characterized by its low skin irritation and high skin penetration, showcasing an advanced method for delivering medication effectively.

Career Highlights: Throughout his career, Hae-Sun Kim has contributed to the pharmaceutical field through various roles in prominent companies. Notably, he has worked with Dong-A ST Co., Ltd. and Km Transderm Ltd., where his focus on innovative drug delivery systems has been pivotal in advancing treatment options.

Collaborations: Hae-Sun Kim has also collaborated with notable individuals such as Sun-Woo Jang and Chang-Yell Shin. These partnerships reflect a commitment to teamwork and innovation in developing cutting-edge solutions to complex medical challenges.

Conclusion: The contributions of Hae-Sun Kim to the realm of dementia treatment are invaluable. His patent for a percutaneous absorption preparation highlights his innovative approach and dedication to improving patient care. As the field of pharmaceuticals continues to evolve, inventors like Kim play a crucial role in shaping the future of medical treatments.